Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion

8 Dec 2021

Abstract excerpt

Gliomas with chromosome 1p/19q codeletion were considered a specific tumor entity. This study was designed to reveal the biological function alterations tightly associated with 1p/19q codeletion in gliomas. Clinicopathological and RNA sequencing data from glioma patients were obtained from The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases. Gene set variation analysis was performed to explore the...

Source

Identifiers

PMID: 34956239
DOI: 10.3389/fimmu.2021.800928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q CodeletionPMID 34956239Read ↗

A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.Semantic proximity Read ↗

A 1p/19q Codeletion Associated Immune Signature for Predicting Lower Grade Glioma PrognosisSemantic proximity Read ↗

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade gliomaSemantic proximity Read ↗

Comparison of Low-Grade Gliomas Molecular Features and Survival by 1p/19q Codeletion in The Cancer Genome AtlasSemantic proximity Read ↗

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in GliomaSemantic proximity Read ↗

Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.Semantic proximity Read ↗

Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses.Semantic proximity Read ↗

DNAJC10 Correlates with Tumor Immune Characteristics and Predicts the Prognosis of Glioma PatientsSemantic proximity Read ↗

High expression of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) predicted poor prognosis in Glioblastoma multiformeSemantic proximity Read ↗

1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.Semantic proximity Read ↗

GPGPS: a robust prognostic gene pair signature of glioma ensembling IDH mutation and 1p/19q co-deletion.Semantic proximity Read ↗

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.